TeamDrive
RUS

Domain Associates

www.domainvc.com

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2.7 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics.  The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 260 life-sciences companies.  The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.

www.dri.com.ru

Domain Russia Investments (DRI) is a company formed by U.S.-based life sciences venture capital firm Domain Associates to help foster innovation in the Russian health sciences sector. DRI plays a crucial role in Domain’s unique strategic collaboration with Rusnano. The collaboration focuses on co-investment into leading US life sciences companies and the eventual production of their innovative healthcare products for the Russian and CIS market.

Media Center

  • 20 June 2018

    First Russian intradermal implant obtained registration

    The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade as part of the state policy of import substitution.

  • 20 June 2018

    EEC changed rules for registration of vaccines and use of GMP certificates

    The Council of the Eurasian Economic Commission (EEC) has amended the rules for registration and expert examination of medicinal products for human use in the Eurasian Economic Union. In particular, it adopted common approaches to the procedure for changing the registration documents for flu prevention vaccines.

  • 19 June 2018

    Russia is ready to supply insulin to Bulgaria

    The time has come to reduce imports from abroad and start establishing contacts with neighbors,” said Ivan Zarubin, acting Trade Representative of the Russian Federation in the Republic of Bulgaria, speaking at the Medicine and Pharmacy 2018, a Bulgarian-Russian business forum held in Sofia on June 13.

  • 19 June 2018

    Construction of a new pharmaceutical plant started in Usolye-Sibirskoye

    An official ceremony marking the launch of construction was held at the site of future plant for active pharmaceutical substances and finished medicinal products of Pharmasyntez-Chemie in Usolye-Sibirskoye on June 15.

Read more